Carbapenemase Gene Spread in CREC Across Guangdong

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) is an important component of the wider carbapenem-resistant Enterobacteriaceae problem. Resistance in this organism is frequently associated with carbapenemase-encoding genes (CEGs), which can hydrolyze carbapenem drugs and undermine a central beta-lactam antibiotic mechanism. The concern is not limited to resistance in individual isolates: genes located on mobile plasmids can move between bacteria, while successful clones can persist and disseminate across clinical departments.

The reference study addressed a timely question: how are CEGs distributed between chromosomes and plasmids in CREC, how readily can they transfer, and what genetic or epidemiological patterns indicate local dissemination? The question is particularly relevant after the COVID-19 pandemic, when altered healthcare delivery, increased antibiotic exposure, and complex infections may have changed selection and transmission conditions. The investigation focused on isolates collected from eight teaching hospitals in Guangdong province, China, between December 2022 and June 2024. The full report is available in Chen et al., BMC Microbiology.

Key Innovation from the Reference Study

The main innovation was an integrated transmission analysis rather than a single resistance screen. The researchers did not stop after detecting blaNDM-1, blaIMP, or blaKPC-2 by PCR. They combined variable-temperature SDS plasmid elimination with PCR to investigate whether resistance genes were plasmid-borne, chromosomal, or present in both locations. They then used plasmid conjugation to test transferability, examined mobile genetic elements, and applied ERIC-PCR with NTSYS analysis to assess relationships among isolates.

This design separates several biological processes that are often conflated. A resistance gene may spread vertically because a successful bacterial lineage expands, horizontally because a plasmid transfers into a new host, or through both pathways. By combining gene localization, in vitro transfer, mobile-element profiling, and strain genotyping, the study provides a more informative picture of dissemination than prevalence data alone. It also connects molecular resistance biology with hospital epidemiology, allowing the authors to ask whether related strains appeared in different departments and institutions.

The work is therefore useful for antimicrobial resistance research because it treats transmission as a layered phenomenon. The result is not a proof of patient-to-patient transmission for every isolate, but it is a practical framework for identifying which resistance determinants have the greatest capacity to move through a healthcare network.

Methods and Experimental Design Insights

The study analyzed 54 CREC isolates from the eight hospitals. CEG detection and localization were examined using PCR before and after variable-temperature SDS-based plasmid elimination. This strategy is informative because loss of a plasmid-associated signal after plasmid elimination supports a plasmid location, whereas persistence of the signal suggests chromosomal carriage. Detection of the same gene in both fractions is consistent with dual localization, although definitive physical mapping would require higher-resolution genomic methods.

Antimicrobial susceptibility was assessed by broth microdilution. The tested agents included imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. The study compared resistance patterns between CEG-positive and CEG-negative groups, providing a phenotypic context for the molecular findings. Conjugation experiments supplied a functional test of horizontal transfer: recipient acquisition was evaluated by PCR, rather than inferred solely from the donor genotype.

Mobile genetic elements were also characterized. The analysis identified six element types and evaluated their coexistence within isolates, with particular attention to ISEcp1. Finally, ERIC-PCR and NTSYS software grouped the isolates into genotypes. This combination offers useful resolution for a surveillance study, while remaining more accessible than whole-genome sequencing in laboratories where sequencing infrastructure is limited.

Protocol Parameters

• Study population: Analyze CREC isolates recovered from multiple hospitals and clinical departments; the reference investigation used 54 isolates collected across eight Guangdong teaching hospitals during December 2022–June 2024, as reported in the reference study.
• CEG localization: Apply the reported variable-temperature SDS plasmid elimination workflow before PCR. The full article’s experimental schedule should be followed rather than replacing it with an assumed fixed-temperature procedure.
• Phenotypic testing: Use broth microdilution to compare CEG-positive and CEG-negative isolates across the selected antibiotics. Maintain consistent inoculum preparation, controls, and interpretive criteria across hospitals; these are workflow recommendations, not additional parameters reported in the study summary.
• Transfer assessment: Pair plasmid conjugation with PCR confirmation in recipient cells. A transfer phenotype should not be assigned from sequence detection in the donor alone.
• Genetic context: Record mobile genetic elements and their combinations alongside the resistance gene. This helps distinguish a gene’s presence from the genetic structures that may facilitate movement.
• Strain relatedness: Use ERIC-PCR and software-based clustering as a practical screening approach, but confirm important outbreak or transmission hypotheses with higher-resolution sequencing where available.

Core Findings and Why They Matter

CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the collection. The distribution was dominated by blaNDM-1. Eighteen isolates, or 33.33%, carried blaNDM-1 on both chromosomes and plasmids, while 25 isolates, or 46.30%, carried blaNDM-1 exclusively on plasmids. Two isolates carried only plasmid-associated blaIMP, and one carried both plasmid-associated blaNDM-1 and blaKPC-2. These results, including the denominators and percentages, are reported in the reference paper.

The high proportion of plasmid-associated blaNDM-1 is particularly important. Chromosomal persistence can stabilize resistance within a lineage, whereas plasmid carriage creates an opportunity for horizontal gene transfer across compatible bacterial hosts. Dual localization may provide both forms of persistence. The study therefore supports a model in which CREC resistance is maintained through the interaction of clonal survival and mobile genetic reservoirs.

CEG-positive isolates showed significantly higher resistance rates than the CEG-negative group for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, with statistical significance reported at P < 0.05. The result is consistent with a clinically difficult multidrug-resistant phenotype, although the association should not be interpreted as proof that every resistance trait is caused by the detected carbapenemase gene. Co-resident genes, permeability changes, efflux, and other mechanisms may contribute.

Conjugation produced the most direct evidence of transfer potential. CEG transfer was successful in 44 of 46 tested donor isolates, or 95.65%. The reported success rates were 42 of 44 for blaNDM-1, two of two for blaIMP, and zero of one for blaKPC-2. These results distinguish gene-specific transfer behavior and show why testing a single representative isolate would be inadequate. The findings indicate that blaNDM-1 was not merely prevalent; it was also highly transferable under the experimental conditions.

ISEcp1 was the most frequently detected mobile genetic element, appearing in 47 of 54 isolates, or 87.04%. Isolates carrying four mobile-element types simultaneously were the largest group, comprising 22 of 54 isolates, or 40.74%. Such combinations may create a genomic environment favorable to resistance-gene mobilization, although the study does not establish the precise transposition event or causal contribution of each element.

ERIC-PCR and NTSYS classified the 54 isolates into 17 genotypes. Types E and G were each detected in 11 isolates, or 20.37%, and originated from different departments in five hospitals. Two type E isolates shared a Dice coefficient of 100%. These data suggest that related strain backgrounds occurred across institutional and departmental boundaries, but ERIC-PCR similarity alone cannot prove a common transmission chain.

The epidemiological profile was also uneven: men accounted for 35 isolates, elderly patients for 39, respiratory medicine for 11, and sputum specimens for 18. The corresponding proportions were 64.81%, 72.22%, 20.37%, and 33.33%, respectively, according to the study report. These observations can guide sampling priorities, but they should not be treated as population-level risk estimates because the sample was hospital-based and relatively small.

Comparison with Existing Internal Articles

The internal article Transmission of Carbapenemase Genes in CREC During COVID-19 provides a concise AMR-focused overview of the same Guangdong investigation, emphasizing plasmid-borne blaNDM-1 and transfer potential. The reference paper extends that summary by documenting the analytical sequence used to localize genes, test conjugation, characterize mobile elements, and compare strain genotypes. Researchers seeking evidence for experimental interpretation should therefore use the primary report rather than relying on a secondary synopsis.

A separate resource, Cefotaxime: Mechanistic Leverage in AMR Model Innovation, discusses antibiotic-oriented experimental design and resistance modeling. Its perspective is complementary but addresses a different level of analysis: it concerns how an antibiotic may be incorporated into laboratory workflows, whereas the Guangdong study investigates carbapenemase gene distribution and transfer in clinical CREC isolates. The two should not be treated as interchangeable evidence.

Limitations and Transferability

Several limitations shape how the findings should be used. The sample came from eight teaching hospitals in one province and covered a defined collection period, so the observed gene frequencies may not represent all hospitals in China or other geographic regions. The sample size also limits subgroup comparisons, particularly when individual gene classes or clinical departments contain few isolates.

The methods provide strong complementary evidence but do not replace whole-genome analysis. SDS plasmid elimination and PCR can support localization, yet they may not resolve complex plasmid structures or distinguish closely related replicons. Conjugation demonstrates transfer under laboratory conditions, not the frequency of transfer in patients, wastewater, or hospital environments. Similarly, ERIC-PCR is useful for screening relatedness but has lower discriminatory and phylogenetic resolution than genome-wide sequencing.

The association between CEG carriage and broader multidrug resistance is biologically plausible, but the dataset does not by itself assign each phenotype to a particular gene. Future studies could combine long-read or hybrid sequencing with longitudinal sampling, patient-level antibiotic exposure data, environmental surveillance, and standardized interhospital genomic comparisons. Those additions would help separate repeated introduction, local clonal expansion, and independent plasmid transfer.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

Translating a hospital surveillance result into a laboratory bacterial infection model can help researchers test selective pressure, resistance emergence, or antibiotic susceptibility under controlled conditions. That bridge is useful but remains indirect: the reference study establishes gene distribution and transfer potential in CREC, not the performance of a particular compound in a model system. Any laboratory extension should therefore preserve the study’s emphasis on appropriate controls, gene confirmation, and cautious interpretation of transfer.

Protocol Parameters

• Compound handling: Researchers using Cefotaxime (SKU BA1012), a third-generation cephalosporin antibiotic, should consult the product information for preparation, storage, and assay-specific compatibility.
• Storage and preparation: The product information specifies solid storage at -20°C and recommends prompt use of freshly prepared solutions rather than long-term solution storage. These are product-handling instructions, not parameters from the Guangdong CREC study.
• Model interpretation: In antimicrobial resistance research or a bacterial infection model, distinguish baseline susceptibility testing from selection experiments and document the isolate’s CEG status. Cefotaxime can provide a beta-lactam comparator when studying beta-lactam antibiotic mechanism, including work involving Gram-positive bacterial infections or Gram-negative bacterial infections, but it does not substitute for carbapenemase localization or conjugation assays.

This resource is intended for research use only. The central practical lesson from the reference study is that resistance surveillance is strongest when phenotype, gene location, mobility, and strain relatedness are measured together.